Personalized correction of sarcopenia in children with nutritional insufficiency: results of a five-year follow-up

GASTROENTEROLOGY AND DIETOLOGY

Keywords:
sarcopenia children nutritional insufficiency dysphagia enteral nutrition metabolic therapy follow-up cerebral palsy саркопения дети нутритивная недостаточность дисфагия энтеральное питание метаболическая терапия катамнез детский церебральный паралич

Abstract

Introduction.Sarcopenia in children with nutritional insufficiency is associated with an unfavorable prognosis, yet effective treatment strategies and optimal follow-up duration remain uncertain. This study presents the results of a 5-year follow-up of patients receiving personalized correction.Aim— to evaluate the effectiveness of a personalized algorithm for the correction of sarcopenia in children with nutritional insufficiency based on the results of a 5-year follow-up.Materials and methods.The follow-up group included 18 patients (all girls) with sarcopenia against the background of nutritional insufficiency: 17 with cerebral palsy (GMFCS (Gross Motor Function Classification System) levels III–V) and 1 with Crohn’s disease. The median age at the time of diagnosis was 9.0 [7.0; 13.0] years. The follow-up duration was 5 years. Treatment included correction of dysphagia, individualized selection of enteral nutrition (polymeric, semi-elemental formulas), metabolic therapy (vitamins B1, B6, B12, E, D) and probiotics. Effectiveness was assessed by body composition dynamics (bioelectrical impedance analysis) and anthropometry.Results.Resolution of sarcopenia was achieved in 13 (72.2%) patients. The median time to resolution was 4.0 years (95% CI 2.1–5.9), mean time — 3.6 years (95% CI 2.8–4.3). Dysphagia correction (nasogastric tube or gastrostomy placement) and metabolic therapy significantly improved outcomes (p=0.004 and p=0.041, respectively). Transition to extensively hydrolyzed protein formulas did not affect the rate of sarcopenia resolution (p=0.794).Conclusion.Personalized correction of sarcopenia including dysphagia management, nutritional support and metabolically oriented vitamin therapy allows sarcopenia resolution in 72.2% of children with nutritional insufficiency with a follow-up duration of at least 3.5 years.

Author Biographies

Milena N. Yakovleva, Saint Petersburg State Pediatric Medical University

pediatrician, nutritionist, assistant, Department of Propaedeutics of Childhood Diseases with a course in general child care named after V.V. Yuryev

Valeria P. Novikova, Saint Petersburg State Pediatric Medical University

Dr. Sci. (Med.), Professor, Head of the Department of Propaedeutics of Childhood Diseases with a Course in General Child Care named after V.V. Yuryev

Anna N. Zavyalova, Saint Petersburg State Pediatric Medical University

Dr. Sci. (Med.), Professor of the Department of Propaedeutics of Childhood Diseases with a Course in General Child Care named after V.V. Yuryev

Irina S. Novikova, Saint Petersburg State Pediatric Medical University

infectious disease specialist, pediatrician, assistant, Department of Propaedeutics of Childhood Diseases with a course in general child care named after V.V. Yuryev

Maria N. Kachalova, Saint Petersburg State Pediatric Medical University; Social Services House “Vmeste”

Pediatrician, Head of the palliative care department Social Services House “Vmeste”; Laboratory Assistant, Department of Propaedeutics of Pediatric Diseases with a Course in General Child Care

References

1. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr. 1997;27(5 Suppl):990S–991S. https://doi.org/10.1093/jn/127.5.990S.

2. Cruz-Jentoft A.J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019:48(1):16–31. https://doi.org/10.1093/ageing/afy169. Erratum: Age Ageing. 2019;48(4):601. https://doi.org/10.1093/ageing/afz046.

3. Завьялова А.Н., Новикова В.П., Яковлева М.Н. Саркопения у детей: лекция. Медицинский совет. 2024;18(1):245–253. https://doi.org/10.21518 /ms2023-470.

4. Ooi P.H., Thompson-Hodgetts S., Pritchard-Wiart L. et al. Pediatric sarcopenia: a paradigm in the overall definition of malnutrition in children? J Parenter Enteral Nutr. 2020;44(3):407–418. https://doi.org/10.1002/jpen.1681.

5. Safer U., Kaplan M., Safer Binay V. Evaluation of sarcopenia in children. J Surg Res. 2019;237:112. https://doi.org/10.1016/j.jss.2018.03.008.

6. Завьялова А.Н., Новикова В.П., Яковлева М.Н. Саркопения у детей с детским церебральным параличом: факторы риска и критерии диагностики (пилотное исследование). Профилактическая и клиническая медицина. 2024;(1):14–24. https://doi.org/10.47843/2074-9120_2024_1_14.

7. Blagec P., Sara S., Tripalo Batoš A. et al. Magnetic resonance imaging can be used to assess sarcopenia in children with newly diagnosed Crohn‘s Disease. Nutrients. 2023;15(17):3838. https://doi.org/10.3390/nu15173838.

8. Jeon I., Bang M.S., Lim J.Y. et al. Sarcopenia among adults with cerebral palsy in South Korea. PM&R. 2019;11(12):1296–1301. https://doi.org/10.1002/pmrj.

9. Грицинская В.Л., Новикова В.П. Нутритивный статус пациентов с детским церебральным параличом (обзор и систематический анализ публикаций). Медицина: теория и практика. 2023;8(3):72–81. https://doi.org/10.56871/MTP.2023.68.48.007.

10. Клочкова О.А., Куренков А.Л. Мышечная слабость и утрата двигательных навыков у пациентов с детским церебральным параличом. Вопросы современной педиатрии. 2020;19(2):107–115. https://doi.org/10.15690/vsp.v19i2.2103.

11. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985;39(1):5–41.

12. Ерпулёва Ю.В. Клиническое питание у детей. М.: ГЭОТАР-Медиа; 2023. 144 с.

13. Иванов Д.О., Завьялова А.Н., Новикова В.П. и др. Влияние пищевого субстрата и способа кормления на компонентный состав тела у пациентов с церебральным параличом. Профилактическая и клиническая медицина. 2022;(3):15–27. https://doi.org/10.47843/2074-9120_2022_3_15.

14. Рахмаева Р.Ф. Диагностика и коррекция нарушений нутритивного статуса у детей с детским церебральным параличом. Автореф. дис. … канд. мед. наук. Казань; 2021. 18 с.

15. Горбачева И.В., Кузнецова О.Ю., Гильмиярова Ф.Н., Печкуров Д.В. Оценка степени тяжести белково-энергетической недостаточности у детей: пируват как биохимический индикатор дефицита мышечной массы. Вопросы практической педиатрии. 2023;18(4):20–26. https://doi.org/10.20953/1817-7646-2023-4-20-26.

16. Newman J.C., Verdin E. β-Hydroxybutyrate: a signaling metabolite. Annu Rev Nutr. 2017;37:51–76. https://doi.org/10.1146/annurev-nutr-071816-064916.

17. Таранушенко Т.Е., Захарова И.Н. Гиповитаминоз D: клинические дискуссии и новые рекомендации Международного эндокринологического сообщества (предложения Endocrine Society). Медицинский совет. 2024;(19):22–28. https://doi.org/10.21518/ms2024-444.

18. Борискина О.Л. Патогенетические механизмы саркопении при хроническом гемодиализе. Дис. … канд. мед. наук. СПб.; 2024. 164 с.

19. Chen L.K., Liu L.K., Woo M.J. et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. https://doi.org/10.1016/j.jamda.2013.11.025.

20. Камалова А.А., Рахмаева Р.Ф., Ахмадуллина Э.М., Басанова Л.И. Оценка эффективности коррекции нутритивного статуса у детей с детским церебральным параличом. Российский вестник перинатологии и педиатрии. 2021;66(4):135–140. https://doi.org/10.21508/1027-40652021-66-4-135-140.

21. Титова О.Н., Таран Н.Н., Строкова Т.В. и др. Оценка эффективности использования смеси на основе гидролизата сывороточного белка для нутритивной поддержки детей с детским церебральным параличом. РМЖ. Медицинское обозрение. 2020;4(5): 282–289. https://doi.org/10.32364/2587-6821-2020-4-5282-289.